APAC Biotech Pvt.Ltd. is a leading biotechnology company which is involved in research based Dendritic cell based therapy and preparing the formulation to impede the growth of cancer cells Our endeavour is to improve the life expectancy by providing safe and effective cell based therapy for cancer patients. Our formulation has been developed after a thorough research based on the principles of immunotherapy. Our active immunotherapies target not only regular tumour cells, but also the cancer stem cells believed to be the cause of cancer growth and recurrence. Our prime objective is to boost the immune system naturally through our novel dendritic cell based therapy and help them fight against malignant tumours.
We have a committed team of qualified scientists and doctors who work round the clock. We have a 1000 class clean room facility, equipped with state of art equipment.
We started working on Dendritic Cell Therapy with the vision of providing a new and effective modality of treatment for cancer. This therapy is based on the principles of immunotherapy which is fast finding its acknowledgement and is being researched upon across various parts of globe for its effective usage in treating dreaded diseases like cancer. The primary benefit of this therapy is being autologous it enhances the immune system of the patient with minimal toxicity, as compared to other conventional methods of cancer treatment. Today as we stand a few steps ahead from where we started, we recall the struggle and challenges involved in the execution of this project but it was brevity of the team and support from our partner organizations which gave us the determination to fight the challenges at every front. The mission of helping out cancer patients and reducing their agony was such strong in our minds that helped us mitigate any challenges that we faced on our way till here and we are committed to tread the path standing united for a grand success and emerge as winners. Research and technology indicators across the globe suggest that the emergence of biotechnology and IT, are closely aligned with global and societal priorities, and primary drivers of economic growth that will dominate the future. Biotechnology is already transforming health care and opening up enormous possibilities for sustainable resource management, transforming many and enabling new areas of research. We at APAC Biotech have also taken a few initiatives in diverse areas of research in collaboration with renowned organizations/ bodies for finding effective usage of DC therapy in treatment of many perilous diseases.We’re working hard to make a progress on all our projects and shall keep you updated at regular intervals through our articles
and newsletters. I thank all of you for your support and for your many contributions to APAC Biotech in its endeavors.
Managing Director & CEO
Dendritic Cell therapy has tremendous potential to improve the lifespan of cancer affected folks across the globe, especially in a developing country like ours. Realizing the great potential of DC therapy in the field of Oncology, APAC Biotech (P) Ltd. was established at Gurgaon. We have come a long way since starting our journey in 2010. Continuing the fine traditions of dendritic cell research, our laboratory offers arguably the best formulation in the field of cancer treatment for real world impact,
based on a foundation of excellence in research. The research activities at the lab cover a wide spectrum of activities, including dendritic cell research to develop a formulation for the treatment of cancer patients. After our concerted efforts on research and approvals from leading hospitals across India we initiated with in vitro studies followed by trials in 2011 and since then there has been no looking back. We believe that in today’s world true innovation has to be open, collaborative, global and multi-disciplinary.
We work closely with leading oncologists, specialized medical advisors, research organizations, hospitals and regulatory bodies. Taking collaborative innovation to the next level we have come up with a new research study in Recombinant Proteins. In medical research and development in the country, we deal with the unique challenges that we face in our day-to-day operations (e.g., Lack of awareness, inadequate parallel infrastructure, scalability, Logistics support, price sensitivity and regulatory challenges etc.) and target innovative solutions that have the potential to enable leapfrogging and be applied to the rest of the world. In recognition of
the contributions made by APAC Biotech for clinical trials of DC therapy We are spreading our wings by undertaking research activities and initiatives to explore the potential use of DC therapy towards cure of multiple diseases which has kept the medical fraternity incapacitated for several years for the lack of treatment and aspire to become a leading research Laboratory in India offering therapies to such medical conditions. These activities are largely directed towards two major focus areas, services research and breakthrough solutions for potentially hazardous diseases. Our focus areas are derived from the dynamics of the unique environment in India, which is fast emerging as a Global Medical Holiday destination and has become a major centre for medical services globally, beyond being poised as becoming one of the largest economies in the world. As we see the world going through rapid changes, the opportunity for research has never been better. We at APAC Biotech, with its best-of-class scientist / researchers and an enviable culture of innovation are helping build a better world for all of us – cancer patients & their families, our partners, our employees and the communities we work with. We invite you to join us in this exciting journey….
Dr. Bandana Sharan